ß-catenin degradation is initiated following phosphorylation by glycogen synthase kinase 3 beta (GSK3ß) [7], [8], a kinase counteracting cardiac hypertrophy [9], inhibiting apoptosis and fibrosis and thus increasing cardiac contractility [10], [11]. The gene discussed is GSK3B; the disease is cardiac hypertrophy.